Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
resulting in a water-soluble compound
QDx21) in a dose-dependent manner and causes tumor regression at 100 mg/kg in H146 xenograft model
4-DPCA treatment suppresses connective tissue ingrowth in porous porous poly (lactic-co-glycolic acid) (PLGA) discs implanted in the peritoneal cavity for 28 days in mice
): Indication: For the treatment of primary biliary cholangitis [Internet]
is a potent and selective inhibitor of NUAK1 (IC50 = 100 nM) and does not affect the activity of a panel of 139 other kinases
Desvenlafaxine Catalog No.:M8458-2 resulting in a water-soluble compoundDesvenlafaxine (brand name: Pristiq, Desfax), also known as O desmethylvenlafaxine, is an antidepressant of the serotonin norepinephrine reuptake inhibitor (SNRI) class developed and marketed by Wyeth (now part of Pfizer). Desvenlafaxine is a synthetic form of the major active metabolite of venlafaxine (sold under the brand names Effexor and Efexor). It is being targeted as the first non hormonal based treatment for menopause. Desvenlafaxine is a